What they were paid
Apellis Pharmaceuticals Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $92,500 | $199,992 | $199,973 | — | $492,465 |
| FY2023 | $90,625 | $199,962 | $205,372 | $0 | $495,959 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Apellis Pharmaceuticals, Inc. DEF 14A filed April 23, 2025, accession 0000950170-25-056966, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Apellis Pharmaceuticals, Inc. filed document, accession 0000950170-25-056966. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.
That is Alec Machiels’s FY2024 figure, as filed. The FY2025 figure the day it is filed: one email, nothing else.
Saved. One email when Alec Machiels’s next annual disclosure lands here, with the figure.
One email when Alec Machiels’s next annual disclosure is on this page, with the figure. Nothing else is sent.
Get the Apellis Pharmaceuticals Board Governance Report
$492,465 Alec Machiels, FY2024 total director compensation
$499
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 23, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2024Apellis Pharmaceuticals pays directors a $50,000 cash retainer and $400,000 in Options and RSUs.
Committees
FY2024 · as the proxy prints themAudit (Chair) · Compensation · Compliance
The rest of the Apellis Pharmaceuticals board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| A. Sinclair Dunlop | Independent Director | $477,465 |
| Cedric Francois | Director | — |
| Craig Wheeler | Independent Director | — |
| Gerald Chan | Independent Director | $498,715 |
| Keli Walbert | Independent Director | — |
| Paul Fonteyne | Independent Director | $487,465 |
| Stephanie Monaghan O'Brien | Director | $484,965 |
The full Apellis Pharmaceuticals compensation record
free company briefThis page is one director within Apellis Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Apellis Pharmaceuticals proxy · each links to its own free briefOrder APLS
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.